Monday, 5 January 2009

Deaf children given implants as babies can learn to speak
London: Experiments conducted by Australian researchers have shown that brain activity in deaf cats develops normally if they are fitted with a cochlear implant shortly after birth.
Rob Shephard, of the Bionic Ear Institute in Melbourne, says that this finding may explain how deaf children given implants as babies can learn to speak almost as well as hearing children.
The researcher points out that in animals with normal hearing, sound vibrates hair cells in the inner ear and thereby trigger neurons to send impulses to the brain.
However, according to him, these hair cells are often defective in deaf animals, and cochlear implants compensate by stimulating neurons directly.
With a view to finding out how this artificial stimulation affects the brain, Shephard and his colleagues recorded electrical activity in the cortex of 17 8-month-old cats that were deaf from birth.
The researchers activated each cat's cochlear implant while monitoring their brains, reports New Scientist magazine.
They said that 10 of the cats had received the implant relatively recently, and their electrical activity was "completely scrambled", indicating that they did not perceive sound coherently: normal cortex activity is key to perceiving sound and, in humans, to developing speech.
However, in the seven cats that received implants at 8 weeks old, brain activity was similar to that in hearing cats.
A research article in the Journal of Comparative Neurology highlights the fact that some deaf people consider it to be unethical to operate on deaf babies, who would otherwise learn sign language.
But neurologist Jim Pickles, of the University of Queensland, says the latest work "increases the weight of evidence to implant children early".

Friday, 2 January 2009

Patterns of brain activity can help predict anxiety treatment success
Washington: American psychologists say that a network of emotion-regulating brain regions, implicated in the pathological worry that can grip patients with anxiety disorders, may also be used to predict whether a patient would benefit from treatment or not.
Jack Nitschke, assistant professor and clinical psychologist at the University of Wisconsin-Madison School of Medicine and Public Health, says that high levels of brain activity in an emotional centre called the amygdala reflect patients' hypersensitivity to anticipation of adverse events.
At the same time, he adds, high activity in a regulatory region known as the anterior cingulate cortex is associated with a positive clinical response to a common antidepressant medication.
In a research article in the online edition of the American Journal of Psychiatry, the lead author writes that for individuals with anxiety disorders, the anticipation of a bad outcome can be worse than the outcome itself.
He points out that some people spend so much time worrying about getting into a negative situation or having a panic attack that the condition becomes debilitating.
"In an extreme situation, they might not even leave their home," he says.
With a view to finding out how the brain responds to anticipation, the researchers used functional magnetic resonance imaging (fMRI) to examine patients with generalized anxiety disorder (GAD) as they viewed a set of negative and neutral images.
The subjects were shown pre-image cues several seconds before each picture, so that they would know what to expect: a circle before a neutral image and a minus sign before an aversive image.
The researchers observed that GAD patients, though did not show any difference compared to healthy subjects in brain activation in response to the aversive or neutral pictures themselves, displayed unusually high levels of amygdala activity in response to both anticipatory cues.
Nitschke said that the response suggested that the patients were hypersensitive to the anticipation of any stimuli, even those they were told would not be negative.
"In response to both of those anticipatory signals, the GAD subjects - the anxious folks - are showing huge amounts of amygdala activation that is much more than what healthy control subjects showed," he said.
He further said that the high levels of amygdala activity seen in GAD patients reflected an indiscriminate and disproportionately large response to the idea that something negative might happen in the future, even in a lab setting where they knew nothing bad would actually occur.
"It suggests that there are differences in anticipatory brain processing in these individuals," he says, adding that the result has important implications for other related disorders as well.
"That's the crux of what's debilitating in people with anxiety disorders, whether it's panic disorder, obsessive compulsive disorder or post-traumatic stress disorder," the researcher said.
Nitschke said that the patterns of brain activity also seemed to hold predictive power for how patients would respond to treatment for their anxiety.
After brain scanning, the GAD patient participating in the study were administered an eight-week course of treatment with a common antidepressant called venlafaxine (Effexor).
The researchers said that clinical improvement on the medication was associated with higher levels of pre-treatment brain activity in the anterior cingulate cortex (ACC) in anticipation of both aversive and neutral stimuli.
They said that activity in the ACC, a regulatory brain region important for modulating emotional responses, has been shown to predict clinical outcome in patients with depression.
"When you look within the GAD patient population, that area is what predicts whether they respond to this treatment. What it suggests is that people who still have some residual functioning of that area are the people who are more likely to get better (with this drug)," says Nitschke.
Since anxiety disorders encompass a range of conditions with diverse symptoms and causes, Nitschke says, it becomes very important to select the most appropriate treatment approach for an individual patient.
Highlighting the fact that anxiety disorders are also frequently associated with depression, Nitschke's team revealed that they were planning to examine GAD patients with and without major depressive disorder.
"This is a critical new direction that the field is already moving in - using fMRI to predict treatment response. Hopefully we'll be able to use that eventually to determine what kind of treatment to provide to people," he said.

Sunday, 28 December 2008

Restless legs could trigger imminent orgasms in women
London: Restless legs and overactive bladder could trigger imminent orgasms in women, according to a study.
Neuropsychiatrist Marcel Waldinger and his colleagues of Utrecht University and The Hague's HagaHospital studied 18 Dutch women with Persistent Sexual Arousal Syndrome (PSAS).
Their findings were recently published in the Journal of Sexual Medicine.
Women affected by this rare and mysterious syndrome experience persistent genital sensations as if they are continuously on the verge of an orgasm.

All participants received in depth interviews and various medical examinations such as MRI-scans of the brain and pelvis. The study showed that most women in this research also had restless legs, symptoms of an overactive bladder and pelvic varicosis.
"These results are a very important breakthrough in the research of this syndrome and show that this is a real physical disorder," Waldinger emphasised.
In 2001, PSAS was mentioned for the first time in medical literature. Only 22 case reports have been described so far. A key feature of the syndrome is that sexual contact does not lead to diminishment but to aggravation of the symptoms. The complaints may lead to desperate and depressive feelings.
The majority of women in the study, the largest on PSAS so far, reported that their complaints were accompanied by restless legs and frequent urge to void.
Some of them reported to have restless legs symptoms long before their genital complaints. MRI-scan and ECHO-Doppler investigations of the pelvis and genitals also demonstrated a high prevalence of pelvic varicosis.
Notably, varicosis and restless legs are associated. The researchers are currently continuing their research on restless legs and bladder functioning in women with PSAS, said a Utrecht University release.
According to Waldinger, PSAS is a genital form of restless legs. Based on scientific observations, he postulated the view that the weird genital sensations are equivalent to the sensations belonging to the Restless Legs Syndrome.
"In order to emphasise this equivalence, we decided to change PSAS into Restless Genital Syndrome (RGS)", Waldinger explained

Saturday, 20 December 2008

A walk in a park a day can help keep mental fatigue at bay
Washington: A simple walk in the park a day can help improve your memory and attentiveness, according to a new study.
The new study led by Marc G. Berman, John Jonides, and Stephen Kaplan from the University of Michigan have found that spending time in nature may be more beneficial for mental processes than being in urban environments.
For the study, the researchers conducted two experiments to test how interactions with nature and urban environments would affect attention and memory processes.
First, a group of volunteers completed a task designed to challenge memory and attention. The volunteers then took a walk in either a park or in downtown Ann Arbor. After the walk, volunteers returned to the lab and were retested on the task.
In the second experiment, after volunteers completed the task, instead of going out for a walk, they simply viewed either nature photographs or photographs of urban environments and then repeated the task.
The results showed that performance on the memory and attention task greatly improved following the walk in the park, but did not improve for volunteers who walked downtown
Moreover, the group who viewed the nature photographs performed much better on the retest than the group who looked at city scenes.
The authors suggest that urban environments provide a relatively complex and often confusing pattern of stimulation, which requires effort to sort out and interpret.
Natural environments, by contrast, offer a more coherent (and often more aesthetic) pattern of stimulation that, far from requiring effort, are often experienced as restful.
The study appears in Psychological Science, a journal of the Association for Psychological Science.
Scientists studying how asbestos fibres cause Cancer
Washington: Ohio State University scientists claim that they are for the first time studying how an asbestos fibre triggers cancer in human cells.
The researchers believe that their work may aid in drug development efforts, aimed towards finding potential cures for illnesses caused by excessive exposure to asbestos, including the deadly cancer called mesothelioma.
With a view to observing how a single asbestos fibre binds with a specific receptor protein on cell surfaces, the research team uses atomic force microscopy.
Study's co-author Eric Taylor, a doctoral candidate in earth sciences at Ohio State, described atomic force microscopy as "Braille on a molecular level", which allows the team to feel what was happening on molecular surfaces.
"We're looking at what molecules are involved in the chain of events when the fibre touches the cell. Does the binding occur over minutes, or hours? And what processes are triggered?" said Taylor, who presented the research at the American Geophysical Union meeting in San Francisco.
So far, the study has been focused to blue asbestos (Crocidolite), a part of the amphibole group of asbestos minerals that were used in such products as ceiling tiles and thermal insulation, before being banned in most of the Western world by the mid-Eighties.
However, the researchers eventually hope to study how all six forms of asbestos interact with certain proteins on cell surfaces.
According to them, some forms of asbestos can dissolve in the lungs if they are inhaled, but others are believed to essentially "stick" to cells, especially at high concentrations, and eventually cause lung diseases.
"For the first time, this will give us data on biological activity that should help policymakers determine which forms of asbestos are the most dangerous," said Steven Lower, associate professor of earth sciences at Ohio State and a co-author on the study.
"The hypothesis we're testing is that binding of cell surface receptors to asbestos fibers triggers a signal event, which initiates the cancer.
"There seems to be something intrinsic about certain types of asbestos, blue asbestos in particular, that elicits a unique signal, and it triggers inflammation, the formation of pre-malignant cells and, ultimately, cancer," added Lower, also a faculty member in the School of Environment and Natural Resources.
The researchers have revealed that the first protein to be studied is epidermal growth factor receptor, which is present on the surface of every human cell.
Lower said that understanding the intricacies of the binding process between the mineral and one or more proteins might provide an index of the biological activity of a particular type of asbestos, and lead the researchers to figure out how to prevent or undo that interaction.
Taylor said that the driving motivation behind the research was the potential to find a way to intervene and prevent illness even after someone was exposed to asbestos.

Sunday, 14 December 2008

Protein expression predicts breast cancer survival in an unexpected way
Washington: A new research led by The University of Texas M. D. Anderson Cancer Center has revealed that the expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy.
In the study, the researchers found that Tau expression does predict survival, yet in an unexpected way.
In previous neoadjuvant studies, researchers from M. D. Anderson found that low levels of Tau predicted a good response to pre-operative chemotherapy.
In vitro studies had shown that down-regulation of Tau expression increased the sensitivity of breast cancer cell lines to paclitaxel.
Other studies suggested that high levels of Tau partially protect microtubules from paclitaxel binding and that low levels of the protein leave microtubules more accessible and vulnerable to the drug.
'If you treat patients who have a low level of Tau protein expression with pre-operative chemotherapy in neo-adjuvant studies, they are very likely to have a good response to the chemotherapy. We wanted to see if this correlation would hold up in predicting survival in adjuvant studies,' said Lajos Pusztai, M.D., D. Phil, associate professor of medicine in the Department of Breast Medical Oncology at M. D. Anderson and the study's first author.
In collaboration with researchers at the National Surgical Adjuvant Breast and Bowel Project (NSABP), the investigators assessed Tau protein expression in primary breast cancer specimens from 1,942 patients in the NSABP-B28 clinical trial.
The aim of the study was to evaluate the prognostic value of Tau in these patients, who were treated with four courses of doxorubicin/cyclophosphamide (AC) or AC followed by four courses of paclitaxel. All hormone receptor-positive patients in the trial also received adjuvant endocrine therapy.
The hypothesis was that patients whose tumours expressed low levels of Tau would preferentially benefit from the addition of paclitaxel to their adjuvant regimen, Pusztai explained.
Univariate and multivariate analyses found that both Tau-positive status (high Tau expression) and estrogen receptor (ER) -positive status were associated with better disease-free and overall survival.
However, the researchers found no significant correlation between Tau expression and benefit from paclitaxel in the total population or among estrogen receptor (ER) -positive or ER-negative patients.
'We eventually found that Tau is very predictive of survival but in the opposite manner than we initially thought,' 'Low Tau expression was actually associated with a relatively poor survival despite a higher sensitivity to chemotherapy,' Pusztai said.
'On the other hand, patients with high levels of Tau-and we knew these patients were not particularly sensitive to chemotherapy-actually did very well. They had a significantly better survival in this large randomized study,' he added.
The study has been presented at the CRTC-AACR San Antonio Breast Cancer Symposium.

Tuesday, 9 December 2008

Contraceptive Methods affect Women's Sexual Pleasure & Satisfaction
Washington: A new study has shown that contraceptive methods can have a significant impact on women's sexual pleasure and satisfaction.
The researchers from The Kinsey Institute at Indiana University have found that many women think condoms decrease sexual pleasure.
On the other hand, those who
use both hormonal contraception and condoms report higher overall sexual satisfaction.
"The public health community has paid little attention to women's sexual experiences with contraceptive methods, especially condoms," said Stephaine Sanders, associate director of The Kinsey Institute and a co-author of the study.
"If women think condoms detract from sexual pleasure, they may be less inclined to use them consistently," she added.
During the study, women admitted condoms make sex less pleasurable, while those who used only hormonal methods-such as the birth control pill-were unlikely to associate their method with decreased sexual pleasure.
When asked about the effect of contraceptives on sexual enjoyment, women who used condoms either alone or with hormonal methods reported decreased sexual pleasure.
However, while considering overall sexual satisfaction, which goes beyond the immediate sexual moment and includes factors such as sexual self-esteem and relationship satisfaction, women who used both condoms and hormonal methods reported the highest levels of sexual satisfaction.
The findings revealed that only 4 percent of women who relied on hormonal methods of contraception reported decreased pleasure, but hormonal users reported the lowest overall sexual satisfaction scores.
While 23 percent of women who used both condoms and hormonal methods reported decreased pleasure, they had the highest sexual satisfaction scores.
Women who used condoms alone or along with a hormonal method were six to seven times more likely to report decreased sexual enjoyment compared to those who used hormonal methods only.
[From Internet]